Ozempic Semaglutide Injection (0.25mg/1.5mL & 1mg/1.5mL )

$190.00$390.00

Active Substance: semaglutide
Common Name: semaglutide
ATC Code: A10BJ06
Marketing Authorisation Holder: Novo Nordisk A/S
Active Substance: semaglutide
Status: Authorised
Authorisation Date: 2018-02-08
Therapeutic Area: Diabetes Mellitus
Pharmacotherapeutic Group: Drugs used in diabetes

In the phase 3 trial that measured outcomes at 20 weeks, most participants were able to reach the full dose and also lost weight as their dose was increased. They saw additional weight loss over the remaining 48 weeks at the full dose.
SKU: N/A Category: